February 20, 2019 / 2:06 PM / 4 months ago

BUZZ-Bausch Health: Climbs on Q4 beat, promising forecast

** U.S.-listed shares of drugmaker climb 2.5 pct to $25.81 premarket

** BHC posts Q4 rev of $2.12 bln and adj EBITDA $858 mln above analysts’ estimates; Also forecasts better-than-expected 2019 rev and adj EBITDA

** Brokerage Stifel says results and forecast show the “first demonstration of potential growth since 2015”

** Co expects 2019 rev of $8.3 bln-$8.5 bln and adj EBITDA of $3.35 bln-$3.50 bln; Mizuho analyst says forecast includes upside from recently acquired products like Trulance

** Stock up 36 pct so far this year (Reporting by Saumya Sibi Joseph in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below